Erythropoietic protoporphyria (EPP) is a rare genetic disorder characterized by a deficiency of the enzyme ferrochelatase, leading to the accumulation of protoporphyrin and causing extreme skin sensitivity to sunlight.
Hyperbaric oxygen therapy may alleviate symptoms in erythropoietic protoporphyria by promoting tissue healing, reducing inflammation, and improving overall cellular function in affected areas.